Race Still Plays Role in U.S. Cancer Death Rates
By Ernie Mundell HealthDay Reporter
FRIDAY, Jan. 12, 2024 -- While cancer death rates have fallen among Americans generally over the past two decades, a new study finds Black Americans are still more likely than whites to die from the disease.
There has been some improvement in closing the gap -- in 2000, Black Americans were 26% more likely to die of cancer than whites, but by 2020 that disparity had shrunk to 12%, researchers at Duke University found.
American Cancer Society statistics show that cancer deaths for all Americans have fallen by a third since 1991.
However, the new analysis finds that "substantial racial and ethnic disparities persisted for many common and preventable cancers," said study co-authors Tomi Akinyemiju and Anjali Gupta.
Akinyemiju is associate professor of population health and global health at Duke's Global Health Institute, and Gupta was a university scholar at Duke when the research was conducted.
The research focused on U.S. National Center Health Statistics data collected between 2000 and 2020. The investigators tracked death rates for the four most common cancers: lung, breast, prostate and colon.
Crunching the numbers, they found that death rates have declined overall, regardless of race.
In 2000, about 252 of every 100,000 Black people died of cancer, and that number had tumbled to about 167 two decades later.
But Black Americans' death rates remained higher than those of whites. White Americans had a cancer death rate of about 198 per 100,000 in 2000 and about 149 per 100,000 by 2020, the Duke team noted.
The racial gap for breast cancer deaths actually widened: In 2000, Black women were 31% more likely than white women to die from the disease, and by 2020 that number had risen to 37%.
Black men face more than double the odds of dying from prostate cancer than white men, and they have a 45% higher odds for fatal colon cancer, compared to their white peers.
Why, despite steady improvements in cancer detection and treatment, do these disparities persist?
According to the researchers, it's probably due to a "confluence of factors" including structural racism, mistrust of the medical profession by some Black Americans, inequities in accessing quality health care, poverty and "aggressive tumor biology" that can be traced to genetics and other factors.
The new findings, published in the Jan. 12 issue of JAMA Health Forum, "underscore the importance of sustained, focused efforts to reduce cancer burden among Black patients across the continuum of cancer care," the researchers wrote.
Sources
- JAMA Health Forum, Jan. 12, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted January 2024
Read this next
Texas Rancher Developed Anthrax From Butchered Lamb Meat
FRIDAY, June 7, 2024 -- Anthrax disease in humans is rare and when it does occur, it's usually during hot, dry summers. That's why the case of a Texas rancher who developed...
Could Brain 'Overgrowth' Contribute to Autism?
FRIDAY, June 7, 2024 -- Severe forms of autism could be linked to overgrowth of the brain’s outer layer that starts while a baby is in the womb, a new study finds. Toddlers...
Patient in Mexico Dies From First Known Human Infection of H5N2 Strain of Bird Flu
THURSDAY, June 6, 2024 -- A 59-year-old person in Mexico is the first human in the world known to be infected with the H5N2 strain of avian flu, and the patient died of...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.